Wolfe Research Upgrades Qiagen to Outperform, Announces $50 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wolfe Research has upgraded Qiagen (NYSE:QGEN) from Peer Perform to Outperform, with a new price target of $50.
June 27, 2024 | 9:51 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Wolfe Research has upgraded Qiagen from Peer Perform to Outperform, setting a new price target of $50.
The upgrade from Wolfe Research and the new price target of $50 is likely to positively impact Qiagen's stock price in the short term as it reflects increased confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100